These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8686264)

  • 1. [Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data].
    Karpovich LG; Kalashnikova TV; Gorbunov MA; Pavlova LI; Bektimirov TA; Maĭdaniuk AG; Sandakhchiev LS; Levina VD; Ermolaeva TN; Rodomazova TA
    Vopr Virusol; 1995; 40(6):268-70. PubMed ID: 8686264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A].
    Ikoev VN; Gorbunov MA; Maĭdaniuk AG; Karpovich LG; Kalashnikova TV; Bektimirov TA; Karpova EV; Nemtsov IuV; Muntlieva MA; Kriuk NI
    Vopr Virusol; 1999; 44(3):133-6. PubMed ID: 10392439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine.
    Cederna JB; Klinzman D; Stapleton JT
    Vaccine; 1999 Dec; 18(9-10):892-8. PubMed ID: 10580203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hep-A-in-Vac, a Russian cultured concentrated inactivated vaccine against hepatitis A].
    Gorbunov MA; Pavlova LI; Rozhkov SD; Kukharev AI; Novikov VIu; Karpovich LG; Kalashnikova TV; Bektimirov TA; Zelenov IA; Levina VD; Belashev BP; Ermolaeva TN; Doroshenko NV; Maĭdaniuk AT
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):50-4. PubMed ID: 9532686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine.
    Ambrosch F; Wiedermann G; Jonas S; Althaus B; Finkel B; Glück R; Herzog C
    Vaccine; 1997 Aug; 15(11):1209-13. PubMed ID: 9286045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.
    Hoke CH; Egan JE; Sjogren MH; Sanchez J; DeFraites RF; MacArthy PO; Binn LN; Rice R; Burke A; Hill J
    J Infect Dis; 1995 Mar; 171 Suppl 1():S53-60. PubMed ID: 7876650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
    Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E
    J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.
    DeFraites RF; Feighner BH; Binn LN; Kanjarpane DD; Delem AD; MacArthy PO; Krauss MR; Krause DS; Moonsammy GI; Hoke CH
    J Infect Dis; 1995 Mar; 171 Suppl 1():S61-9. PubMed ID: 7876651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.
    Just M; Berger R; Dreschsler H; Brantschen S; Glück R
    Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.